The<unk>  is an innovation in therapeutic strategy for<unk>  patients.<unk>  cells (DCs) are antigen presenting cells for the induction of antigen specific T cell response. DC-based immunotherapy is safe and can promote antitumor immune responses and prolonged survival of<unk>  patients.
Dendritic cell-based cancer vaccine
Tumor antigen vaccine
Antigen-presenting cell vaccine
Cancer vaccine targeting CD4+ T cells
Therapeutic vaccines
T-cell vaccination
Viral vector vaccine
Cell-based vaccine